Five-year license issued to “Pharma Essenza Cannabis SA” and “PENTE SA”
A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
NHS promises to lead global elimination of hepatitis C
The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus and lead a global elimination.
London’s Ultra Low Emission Zone is essential to the public’s respiratory health
As London’s new Ultra Low Emissions Zones (ULEZ) came into effect this month, a new animation highlights the effects that air pollution has on the public's respiratory health.
Technology opens new opportunities to increase adult vaccinations
Technology could play a major role in overcoming some of the barriers to the uptake of adult vaccinations argues a new report, “Data, bots and drones”, published by the International Longevity Centre UK (ILC).
What is the reality of eating disorder treatment?
Dr. Lynne Green speaks to Nishat from Open Access Government about NHS eating disorder treatment, what to do if someone is suffering, and how social media has changed the landscape.
Is your commute to work harming your mental health?
Three-quarters of young brits say their commute to work increases their stress levels yet nearly three in five would commute longer for better jobs and homes.
Why is respiratory protection so important?
Paul Riddick, Co-Founder and Technical Director at Vodex explores how contaminates being produced on a daily basis in the workplace can damage your health and could even prove fatal.
NHS rolls out mental health job coaches
NHS England has announced a major expansion of a scheme designed to provide tens of thousands of mental health patients with job coaches to help find employment.
$4.3 million donated to accelerate malaria elimination
Tableau, Mapbox, Exasol, and Alteryx commit $4.3 million to accelerate malaria elimination efforts for more than 60 million people.
Mental health in Germany: A focus on ward-equivalent treatment
Laura Kirschbacher, Corporate Communications Manager at Pfalzklinikum AdöR talks about ward-equivalent treatment (WeT), a special kind of hometreatment, where a multi-professional team visits the patients at home: She accompanied WeT social worker Linda Seez to find out more.
Is your office setup affecting your mental wellbeing?
With employee mental wellbeing hot on the agenda, Brickendon’s research reveals the biggest hot desking pitfalls and how businesses can overcome them.
Over 50% of allergy sufferers at risk in UK
As research finds more than half (58%) of allergy sufferers have had their lives put at risk by restaurant or takeaway staff, law firm Slater and Gordon are calling on businesses to have better allergen control.
Insights: Working with personality disorders
Dr. Jo Gee writes about working with personality disorders through her psychotherapy experience of over 10 years: Read on for what she has to say about mental health treatment.
Chronic obstructive pulmonary disease: Ageing and multimorbidity
It is estimated that more than 3 million people in the UK have chronic obstructive pulmonary disease or COPD.
Modern laws: The psychological impact of racism on healthcare
Here Tamara Muhammad, barrister at One Pump chambers, discusses her insight into the law and the unique psychological impact of racism to ethnic minorities.
50% of millennials would pick CBD oil over prescriptions for mental health
Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
Mind launches free training for organisations to promote wellbeing in the workplace
The new, free training is aimed at organisations of less than 250 people to promote wellbeing in the workplace and is available online at the Mental Health at Work website.
From diabetes prevention 1.0 to Prevention 3.0
Digitally enabled pathway personalisation is leveraging actionable data insights and dynamic intelligence to drive better outcomes as part of the Prevention 3.0 agenda
Immunoscore®: From the science to the clinical evidence in colon cancer
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Napp: Reducing the burden of chronic conditions through partnership
Chronic conditions, such as asthma and diabetes, are creating an increasing burden on the health service.
